Skip to main content

SOPHiA GENETICS SA

SOPH
Exchange
Nasdaq
Industry
Services-Computer Processing & Data Preparation
SEC CIK
0001840706

In the last 90 days, SOPHiA GENETICS SA insiders filed 0 open-market purchases and 27 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $212.5M in total; Akre Capital Management is the only superinvestor holding it.

Q1 2023 vs. Q4 2022

How the institutions holding SOPHiA GENETICS SA changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of SOPH: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders3234+2
Shares19.4M18.3M−1.14M (−5.9%)
Value$40.1M$90.9M+$50.9M (+127.0%)

New holders (5)

Institutions that held SOPHiA GENETICS SA at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to SOPH in Q1 2023
InstitutionSharesValue% of portfolio
Boothbay Fund Management, LLC57,843$287.5K0.01%
Two Sigma Securities, LLC18,129$90.1K0.01%
Jane Street Group, LLC16,091$80.0K0.00%
Nordwand Advisors, LLC2,000$9.94K0.00%
Tower Research Capital LLC (TRC)574$3.00K0.00%

Sold out (3)

Institutions that held SOPHiA GENETICS SA at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of SOPH in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Jennison Associates LLC1,209,055$2.49M
General Electric Co1,111,111$2.29M
Fred Alger Management, LLC152,610$314.4K